Product Main

Quick Details

Purity: 99
Model Number: 164656-23-9
Brand Name: NJBN STEROID
Grade Standard: Medicine Grade
Type: Vitamins, Amino Acids and Coenzymes
Place of Origin: China (Mainland)
EINECS No.: 164656-23-9
MF: C27H30F6N2O2
Other Names: Dutasteride
CAS No.: 164656-23-9
Sample: Free
Market: Worldwide

Specifications

Dutasteride 164656-23-9 Treatment Of Benign Prostatic Hyperplasia

Product Name: Dutasteride 
Synonyms: (5alpha,17beta)-n-{2,5-bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-l-ene-17-carboxamide;DUTASTERIDE;GG-745, GI-198745,;5α,17β)-N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4- Aza -androst-1-ene-17-carboxamide;Duagen;(5a,17)-N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-azaandrost-1-ene-17-carboxamide;Avodart;GI 198745 
CAS: 164656-23-9 
MF: C27H30F6N2O2 
MW: 528.53 
Chemical Properties White Crystalline Solid 
Usage Used in the treatment of benign prostatic hyperplasia. Dual inhibitor of 5a-reductase isoenzymes type 1 and 2; structurally related to Finasteride. 

COA

Test Items Specification Test Results
Description White or almost white powder Complies
Identification Meet the requirements Complies
Loss on drying ≤0.5% 0.2%
Melting range 246oC~252oC 246oC~248oC
Heavy metals ≤20ppm Complies
Residue on ignition ≤0.1% Complies
Related substances Biggest Impurities≤0.5% 0.36%
Total Impurity≤1.0% 0.7%
Assay 97.0%~103.0% 99.3%
Conclusion Complies with In-house Standard

Applications 
 
Dutasteride (INN , USAN , BAN , JAN) , developed by GlaxoSmithKline , is a triple 5α-reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone (DHT) . It is used to treat benign prostatic hyperplasia . It increases the risk of erectile dysfunction[3] and decreased sexual desire.

Dutasteride 164656239 Treatment Of Benign Prostatic Hyperplasia